GonGlobal is creating an inhalation substitute for the injections that are frequently needed for in vitro fertilization.
GonGlobal has raised $1.2M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
GonGlobal's investors include RMIT University, Innovation Victoria.
GonGlobal is headquartered in Southbank, Australia.
GonGlobal is creating an inhalation substitute for the injections that are frequently needed for in vitro fertilization.
GonGlobal is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GonGlobal — Funding & Investors." VCBacked, September 1, 2026, https://www.vcbacked.co/company/gonglobal. Accessed October 1, 2026.
VCBacked. (2026). GonGlobal — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/gonglobal
{{cite web |title=GonGlobal — Funding & Investors |url=https://www.vcbacked.co/company/gonglobal |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated